β-glucan-based antiviral therapy for HIV virus:  β-(1, 3)-glucan/Lentinan (LNT), isolated from Lentinus edodes, increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 17/July/2018, 11.39 am

TB/BCG vaccine preserves your heart function against cardiac diseases:  TB/BCG vaccine-based therapy for attenuating pathogenesis-associated with Myocardial infarction:  TB/BCG vaccine decreases IRF3 (Interferon regulatory transcription factor-3), GM-CSF (Granulocyte-macrophage colony-stimulating factor) and GRK2(G protein-coupled receptor kinase) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits ventricular dilation, and promotes heart repair and survival, via up regulation of its target gene, 17/July/2018, 9.00 am
July 17, 2018
Anti-hyperglycemic drug comes to the rescue of blood-stage Plasmodium infection: Ciglitazone, an anti-hyperglycemic drug,  decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clears blood-stage malaria, via up regulation of its target gene, 17/July/2018, 5,50 pm
July 17, 2018
Show all

What we say:

Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: β-glucan-based antiviral therapy for HIV virus:  β-(1, 3)-glucan/Lentinan (LNT), isolated from Lentinus edodes, increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene

[easy_payment currency=”USD”]


From Significance of the study to Public health relevance:

Given that: (1) more than 37 million people worldwide are living with HIV/AIDS; (2) there is no effective vaccine available for HIV/AIDS; (3) HIV/AIDS tops the list of incurable diseases in humans; (4) the life-long painful drug treatment is required to treat HIV/AIDS and its associated opportunistic infections; (5) the global economic cost spent for HIV treatment is enormous, there is an urgent need to find: (i) a way to restore CD4 T-cells that were lost in HIV/AIDS; (ii) a cheaper alternative to the existing expensive antiviral drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, HIV-1/AIDS.


From Research findings to Therapeutic opportunity:

This study suggests, for the first time, β-(1, 3)-glucan-based antiviral therapy against RNA viruses such as HIV-1.

 β-(1, 3)-glucan/Lentinan (LNT), by increasing the expression of its target gene, it may increase the expression of Heme oxygenase-2 (HO-2) (Figure 1). Thereby, it may: (1) bind and block the myristate moiety of HIV-1 Gag protein; (2) disrupt HIV-1 budding; (3) restrict HIV-1 infectivity, replication and production; (4) promote clearance of HIV-1 and MLV virions; and (5) strengthen antiviral immunity against RNA viruses.

Figure 1 Mechanistic insights into how β-(1, 3)-glucan/Lentinan (LNT) functions as an anti-HIV agent. Lentinan (LNT)  inhibits HIV-1 budding and production via up-regulation of its target gene HO-2

Figure 2. The chemical structure of β-(1, 3)-glucan/Lentinan (LNT). It functions as an anti-HIV agent.through induction of its target gene HO-2

Thus, pharmacological formulations encompassing β-(1, 3)-glucan/Lentinan (LNT) or its analogs, either alone or in combination with other drugs,” may be used to inhibit HIV-1 production.

[easy_payment currency=”USD”]


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does  β-(1, 3)-glucan/Lentinan (LNT)  increase the expression of Heme oxygenase-2 (HO-2)?

Amount: $500#

For payment and purchase details, you may reach us at admin@genomediscovery.org

# Research cooperation


References:

Web: http://genomediscovery.org or http://newbioideas.com/

Citation: Boominathan, L., β-glucan-based antiviral therapy for HIV virus:  β-(1, 3)-glucan/Lentinan (LNT), isolated from Lentinus edodes, increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 17/July/2018, 11.39 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite, drop us a line at admin@genomediscovery.org

Comments are closed.